Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve CO handling risks & low yields in quinazolinone synthesis. Discover how solid CO substitute enables safe, scalable production for drug development. Contact for custom synthesis.
Simplify isocoumarin synthesis with copper-catalyzed method: 70-83% yields, no precious metals, easy purification. Reduce R&D costs and supply chain risks for pharmaceutical intermediates.
Solve supply chain risks with this efficient 3-benzylidene-2,3-dihydroquinolone synthesis. High yields (74-93%), broad substrate tolerance, and scalable process for API development.
Eliminate NaN3 hazards in DL-α-aminocaprolactam production. This two-step method offers high yields (81-85%) and simplified purification, reducing supply chain risks for lysine manufacturing.
Discover a cost-effective, high-yield method for 2-trifluoromethyl quinazolinone synthesis. Our CDMO expertise ensures scalable production with >99% purity for your drug development.
Avoid toxic reagents and multi-step purification with this 60-75% yield 3-cyanoindole synthesis. Reduce production costs by 40% for drug development.
Solve low-yield benzoxepin synthesis challenges with this Pd-catalyzed method. 78%+ yields, broad functional group tolerance, and simplified production for drug development.
Solve amide bond formation challenges with this novel palladium-catalyzed method. Achieve high yields, broad functional group tolerance, and reduced waste for your API synthesis. Request a quote today.
Solve high-cost, complex aryl diselenide synthesis with this green method. 95% yield, no anhydrous conditions, ethanol recyclable. Reduce supply chain risks for pharma R&D.
Discover a cost-effective, eco-friendly synthesis method for indole morphinan derivatives with high anti-tumor activity. Reduce production costs and ensure supply chain stability with our scalable process.
Discover a novel sulfur-promoted method for 5-trifluoromethyl-1,2,4-triazole synthesis. Eliminates peroxide hazards, no anhydrous conditions, and ensures high-yield, scalable production for pharmaceutical intermediates.
Solve low-yield and long-cycle issues in Paxlovid intermediate production. Our CDMO expertise delivers 60%+ yield, 99% purity, and industrial-scale reliability.
Eliminate diazonium safety risks with this 80% yield, 99.5% purity process. Reduce wastewater and scale production reliably.
Solve ivabradine production challenges with 95% yield and simplified 5-step route. NINGBO INNO PHARMCHEM offers scalable CDMO solutions for high-purity API manufacturing.
Discover how metal-free hydrodefluorination of trifluoromethyl olefins with 87% yield solves GMP compliance and supply chain risks for pharmaceutical intermediates.
Discover a cost-effective, air-tolerant synthesis of 3-cyanindole intermediates with high yields and simplified process, reducing supply chain risks for pharma R&D and procurement.
Solve C-N bond construction challenges in heterocyclic synthesis with room-temperature amination. 90% yield, easy scale-up for API manufacturing.
Discover a cost-effective, metal-free synthesis method for 5-trifluoromethyl-1,2,4-triazole compounds. Eliminate heavy metal catalysts and simplify supply chain for pharmaceutical intermediates.
Solve high catalyst cost & low ee in chiral α-aminophosphonic acid synthesis. Our CDMO expertise delivers 99% ee with 0.0001% catalyst loading. Scale to 100 MT/yr.
Solve 1,2,3-triazole synthesis challenges: 91% yield, one-pot process, reduced purification costs. CDMO expertise for scalable API production.